The Foreign Investment Promotion Board will take up 41 foreign direct investment (FDI) proposals in its meeting on July 31.
These include proposals from Cadila Healthcare, Apollo Hospitals and Aegon Religare Life Insurance.
Of the 41 proposals, nine are from the pharmaceutical sector. Proposals from pharmaceutical and bio-tech companies, including Akumentis Healthcare, Cairnhill, Windlas Biotech, Kinedex Healthcare, New India Biopharma, Indian Herbs Speciality, and Elanco will be put up for consideration.
Other proposals to be taken up are from companies such as Capricorn Ventures, Almondz Insurance Brokers, IIFL Holdings, Encore Reconstruction, BTI Payments, Bloomberg Data Services, Tata Global Beverages Ltd and News Laundry Media.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.